Nuclear Reprogramming Factors for Reproducible Patient-Specific iPS Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for nuclear reprogramming somatic cells to induce pluripotent stem cells face ethical concerns due to the use of embryos or embryonic stem cells, and often result in rejection upon transplantation, lacking reliable and reproducible techniques for generating pluripotent stem cells with properties similar to ES cells.
Innovation Solution
The use of nuclear reprogramming factors comprising gene products such as Oct family, Klf family, Sox family, Myc family, and cytokines like bFGF and SCF to reprogram somatic cells into induced pluripotent stem cells without eggs, embryos, or embryonic stem cells, ensuring high reproducibility and pluripotency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If nuclear transfer into oocytes or fusion with ES cells is used for reprogramming, then pluripotent stem cells can be generated, but ethical problems and rejection upon transplantation occur
Solution Approach 1:
The invention extracts and uses only the necessary reprogramming factors (Oct3/4, Sox2, Klf4, c-Myc) from ES cells to induce pluripotency in somatic cells, eliminating the need to use actual ES cells or embryos. This extraction approach generates iPS cells that are genetically matched to the patient, avoiding both ethical problems and immune rejection.
Solution Approach 2:
The invention creates a copy of the pluripotent state by introducing reprogramming factors into somatic cells, rather than using actual ES cells. The resulting iPS cells are functional copies of ES cells with similar properties but without the ethical and immunological drawbacks of using real embryos or ES cells.
2Reliability
If cell extracts are used to treat differentiated cells, then reprogramming may occur, but the method is technically unreliable and unsafe
Solution Approach 1:
The invention segments the complex cell extract into individual, identifiable reprogramming factors (Oct3/4, Sox2, Klf4, c-Myc). By isolating and characterizing each factor separately, the method achieves technical reliability and reproducibility while maintaining manageable complexity through systematic identification of essential components.
Solution Approach 2:
The invention changes the parameter of reprogramming factor delivery from undefined cell extract composition to specific, controlled expression of individual transcription factors. This parameter change enables precise control over the reprogramming process, improving reliability and safety while allowing systematic optimization of each factor's contribution.
3Reliability
If ES cells are used for reprogramming, then pluripotent cells can be generated, but rejection upon transplantation occurs
Solution Approach 1:
The invention extracts the essential reprogramming capability from ES cells by identifying and using specific transcription factors (Oct3/4, Sox2, Klf4, c-Myc). This allows generation of patient-specific iPS cells that inherit the patient's own genetic background, ensuring immune compatibility and eliminating rejection while achieving pluripotency.
Data Source
AI summary
A recombinant vector for producing an induced pluripotent stem cell, including an Oct family gene, a Klf family gene, and a Myc family gene, wherein the genes are inserted in the vector and an induced pluripotent stem cell including the recombinant vector. Also disclosed is a method for preparing a recombinant vector for producing an induced pluripotent stem cell, including inserting each of the three genes into a vector such that the genes are capable of expression. Also disclosed are a first recombinant vector for preparing a second recombinant vector for producing an induced pluripotent stem cell, said first recombinant vector including at least two of the following four genes: an Oct family gene, a Klf family gene, a Myc family gene and a Sox family gene. Also disclosed is a method for preparing the first recombinant vector, including inserting the at least two genes into a vector.